v3.25.2
Acquisitions and Divestitures - Schedule of Preliminary Amounts Recognized for Assets Acquired and Liabilities Assumed (Details)
$ in Millions
Apr. 02, 2025
USD ($)
intangibleAsset
Jun. 29, 2025
USD ($)
Dec. 29, 2024
USD ($)
Assets acquired:      
Goodwill (Note 3)   $ 48,117 $ 44,200
Intra-Cellular Therapies, Inc.      
Assets acquired:      
Cash and cash equivalents $ 200    
Marketable securities 600    
Other current & non-current assets 300    
Amortizable intangibles asset 5,200    
Acquired in-process research and development 8,300    
Goodwill (Note 3) 2,900    
Total assets acquired 17,500    
Liabilities assumed:      
Deferred taxes 2,800    
Other current & non-current liabilities 200    
Total liabilities assumed 3,000    
Total assets acquired and liabilities assumed $ 14,500    
Weighted average useful life 8 years    
Number of intangible assets acquired | intangibleAsset 2    
Probability of success factor 95.00%    
Intra-Cellular Therapies, Inc. | Minimum      
Liabilities assumed:      
Acquired finite-lived intangible assets, discount rate 11.50%    
Probability of success factor 3400.00%    
Intra-Cellular Therapies, Inc. | Maximum      
Liabilities assumed:      
Acquired finite-lived intangible assets, discount rate 12.50%    
Probability of success factor 50.00%